Bayer’s Finerenone Approved in India for Heart Failure

India, 6th November 2025: Bayer today announced that its innovative therapy Kerendia™ (finerenone) has received approval in India for the treatment of adult patients with heart failure with a preserved and mildly reduced ejection fraction (HFpEF/HFmr…